No Data
No Data
NeoGenomics Analyst Ratings
Goldman Sachs Maintains NeoGenomics(NEO.US) With Buy Rating, Cuts Target Price to $15
TD Cowen Maintains NeoGenomics(NEO.US) With Buy Rating, Cuts Target Price to $17
Express News | Neogenomics Inc : TD Cowen Cuts Target Price to $17 From $19
BofA Securities Maintains NeoGenomics(NEO.US) With Hold Rating, Cuts Target Price to $12
BofA Securities Adjusts Price Target on NeoGenomics to $12 From $16, Maintains Neutral Rating